These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients. Gurbel PA; DiChiara J; Tantry US Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828 [TBL] [Abstract][Full Text] [Related]
23. The safety of drug-eluting stents. Saia F; Marzocchi A; Branzi A Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):43-52. PubMed ID: 19124407 [TBL] [Abstract][Full Text] [Related]
24. Coronary stents and noncardiac surgery. Riddell JW; Chiche L; Plaud B; Hamon M Circulation; 2007 Oct; 116(16):e378-82. PubMed ID: 17938292 [No Abstract] [Full Text] [Related]
25. Drug-eluting stents: issues of late stent thrombosis. Lemesle G; Maluenda G; Collins SD; Waksman R Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052 [TBL] [Abstract][Full Text] [Related]
26. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833 [TBL] [Abstract][Full Text] [Related]
28. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Garg P; Mauri L Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745 [TBL] [Abstract][Full Text] [Related]
29. A tale of two stents: perioperative management of patients with drug-eluting coronary stents. Head DE; Sebranek JJ; Zahed C; Coursin DB; Prielipp RC J Clin Anesth; 2007 Aug; 19(5):386-96. PubMed ID: 17869994 [TBL] [Abstract][Full Text] [Related]
31. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy. Ayyanathan S; Hersh D; Coplan NL; Garratt K Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578 [TBL] [Abstract][Full Text] [Related]
32. Minimizing the risks of anticoagulants and platelet inhibitors. Alexander KP; Peterson ED Circulation; 2010 May; 121(17):1960-70. PubMed ID: 20439812 [No Abstract] [Full Text] [Related]